반응식
N1(C2N=C3C=CC(N)=CN3N=2)CCCC1.[CH2:16]([O:18][C:19]([C:21]1[CH:22]=[N:23][N:24]([CH3:44])[C:25]=1[C:26](=[O:43])[NH:27][C:28]1[CH:29]=[CH:30][C:31]2[N:32]([N:34]=[C:35]([N:37]3[CH2:42][CH2:41]O[CH2:39][CH2:38]3)[N:36]=2)[CH:33]=1)=[O:20])[CH3:17]>>[CH2:16]([O:18][C:19]([C:21]1[CH:22]=[N:23][N:24]([CH3:44])[C:25]=1[C:26](=[O:43])[NH:27][C:28]1[CH:29]=[CH:30][C:31]2[N:32]([N:34]=[C:35]([N:37]3[CH2:42][CH2:41][CH2:39][CH2:38]3)[N:36]=2)[CH:33]=1)=[O:20])[CH3:17]참가 물질
3
반응물 2
생성물 1
실험 절차
Using 2-Pyrrolidin-1-yl-[1,2,4]triazolo[1,5-a]pyridin-6-ylamine, this compound was prepared following the same method as for the synthesis of 1-methyl-5-(2-morpholin-4-yl-[1,2,4]triazolo[1,5-a]pyridin-6-ylcarbamoyl)-1H-pyrazole-4-carboxylic acid ethyl ester. Brown solid (1.1 g, 65%). MS: m/z=384 (M+H+).
후처리
- customthis compound was prepared
출처 및 근거
- ORD 기록
- ord-83843f4e32c24f81b3c9f8a2677545e1
- 출처 데이터셋
- uspto-grants-2015_02
- 특허 번호
- US08946427B2
연결된 노트
불러오는 중…